Astra Zeneca CEO to Leave Following Weak Results
AstraZeneca PLC said Chief Executive David Brennan is leaving after the troubled drug maker missed its first-quarter earnings and sales forecasts and cut its full-year profit targets yet again. Dow Jones's Sten Stovall reports. Photo: Getty Images
Related Videos
Most Popular Videos
Latest Videos
Most Active by Volume:
| Company | Last Sale | Change Net / % |
|---|---|---|
| BAC | $ 13.43 |
0.07  0.52%
|
| CSCO | $ 24.24 |
0.35 1.48%
|
| MSFT | $ 34.87 |
0.79 2.32%
|
| F | $ 15.08 |
0.44 3.01%
|
| ARUN | $ 13.10 |
4.51  25.61%
|
| SIRI | $ 3.50 |
0.05 1.45%
|
| GE | $ 23.46 |
0.19 0.82%
|
| S | $ 7.32 |
0.04 0.55%
|
Latest News Headlines
HARVEST NATURAL RESOURCES 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana A 10:00PM ET - GlobeNewswire
Shell Reported Power Outage, Issues at Anacortes Refinery 9:37PM ET - Dow Jones Business News
Ericsson, Airvana Reach Agreement in Principle to Settle Trade-Secret Dispute -Bloomberg 8:05PM ET - Dow Jones Business News
Source Says Yahoo CEO Mayer to Announce Updates to Flickr Site at Monday Event -Bloomberg 7:46PM ET - Dow Jones Business News
UPDATE: Apache Board Adjusts CEO Pay Targets After Losing Shareholder Vote 6:44PM ET - Dow Jones Business News